General Information |
Board Constituency: |
Private sector |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Private Sector |
Organization Type - Secondary: |
Company |
Organization Description: |
Enzychem Lifesciences Corporation is a Korean Global New Drug Development Venture founded in July 1999. With its Global New Drug R&D center and its two GMP manufacturing plants,it has since been developing and producing APIs and functional health foods, and developing global new drugs.
1. We are providing high quality APIs for MDR-TB. 2. Enzychem Lifesciences develop and manufacture D-Cycloserine & Terizidone for MDR-TB Drugs' APIs. 3. We'd like to help TB patients with our products and experiences.
the field.
|
|
Do you know about the UNHLM declaration: |
|
Other Organization Information |
Total number of staff in your organization: |
51 - 99 |
Number of full-time staff who are directly involved with TB: |
11 - 25 |
Number of part-time staff who are directly involved with TB: |
0 |
Number of volunteers who are directly involved with TB: |
11 - 25 |
|
How did you hear about the Stop TB Partnership: |
Other partners |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Network with other partners |
|
Are you a member of a Stop TB national partnership: |
No |
Are you in contact with your national TB programme: |
No |
Please tell us how your organization is contributing to your country's national TB control plan: |
We are manufacturing APIs for MDR-TB such as D-cycloserine and Terizidone. |
|
Geographical Reach |
Which country is your headquarters located in: |
Republic of Korea |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
India Indonesia Kazakhstan Malaysia |